Advertisement
Screener

INTEGRATED BIOPHARMA INC (INBP) Cost of Revenue

2.0 / 5 stars · 47/116 Roast Me

INTEGRATED BIOPHARMA INC Cost of Revenue

INTEGRATED BIOPHARMA INC (INBP) reported Cost of Revenue of $10.38 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.

Financial Statements › Expense Statement

us-gaap:CostOfGoodsAndServicesSold · last filed 2026-05-08

  • INTEGRATED BIOPHARMA INC cost of goods and services sold for the quarter ending 2026-03-31 was $10.38M, a 16.24% decline year-over-year.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for the quarter ending 2025-12-31 was $11.25M, a 1.68% decline year-over-year.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for the quarter ending 2025-09-30 was $11.67M, a 4.70% decline year-over-year.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for the quarter ending 2025-06-30 was $12.71M, a 10.85% increase year-over-year.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for fiscal 2025 was $48.79M, a 5.08% increase from fiscal 2024.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for fiscal 2024 was $46.43M, a 0.38% decline from fiscal 2023.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for fiscal 2023 was $46.61M, a 6.20% decline from fiscal 2022.
  • INTEGRATED BIOPHARMA INC cost of goods and services sold for fiscal 2022 was $49.69M, a 8.11% decline from fiscal 2021.
Period endCost of Goods and Services Sold 3 monthCost of Goods and Services Sold 6 monthCost of Goods and Services Sold 9 monthCost of Goods and Services Sold 12 month
2026-03-31$10.38M
10-Q · filed 2026-05-08
$21.63M
derived: sum of 2 quarters · filed 2026-05-08
$33.30M
10-Q · filed 2026-05-08
$46.01M
derived: sum of 4 quarters · filed 2026-05-08
2025-12-31$11.25M
10-Q · filed 2026-02-11
$22.92M
10-Q · filed 2026-02-11
$35.63M
derived: sum of 3 quarters · filed 2026-02-11
$48.02M
derived: sum of 4 quarters · filed 2026-05-08
2025-09-30$11.67M
10-Q · filed 2025-11-10
$24.38M
derived: sum of 2 quarters · filed 2025-11-10
$36.77M
derived: sum of 3 quarters · filed 2026-05-08
$48.22M
derived: sum of 4 quarters · filed 2026-05-08
2025-06-30$12.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$25.10M
derived: sum of 2 quarters · filed 2026-05-08
$36.55M
derived: sum of 3 quarters · filed 2026-05-08
$48.79M
10-K · filed 2025-09-23
2025-03-31$12.40M
10-Q · filed 2026-05-08
$23.84M
derived: sum of 2 quarters · filed 2026-05-08
$36.09M
10-Q · filed 2026-05-08
$47.55M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$11.44M
10-Q · filed 2026-02-11
$23.69M
10-Q · filed 2026-02-11
$35.15M
derived: sum of 3 quarters · filed 2026-02-11
$47.05M
derived: sum of 4 quarters · filed 2026-02-11
2024-09-30$12.25M
10-Q · filed 2025-11-10
$23.71M
derived: sum of 2 quarters · filed 2025-11-10
$35.61M
derived: sum of 3 quarters · filed 2025-11-10
$46.60M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30$11.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23
$23.36M
derived: sum of 2 quarters · filed 2025-09-23
$34.35M
derived: sum of 3 quarters · filed 2025-09-23
$46.43M
10-K · filed 2025-09-23
2024-03-31$11.90M
10-Q · filed 2025-05-14
$22.89M
derived: sum of 2 quarters · filed 2025-05-14
$34.97M
10-Q · filed 2025-05-14
$46.98M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$10.99M
10-Q · filed 2025-02-13
$23.07M
10-Q · filed 2025-02-13
$35.08M
derived: sum of 3 quarters · filed 2025-02-13
$47.17M
derived: sum of 4 quarters · filed 2025-02-13
2023-09-30$12.08M
10-Q · filed 2024-11-13
$24.09M
derived: sum of 2 quarters · filed 2024-11-13
$36.18M
derived: sum of 3 quarters · filed 2024-11-13
$47.37M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$12.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20
$24.10M
derived: sum of 2 quarters · filed 2024-09-20
$35.28M
derived: sum of 3 quarters · filed 2024-09-20
$46.61M
10-K · filed 2024-09-20
2023-03-31$12.09M
10-Q · filed 2024-05-10
$23.27M
derived: sum of 2 quarters · filed 2024-05-10
$34.60M
10-Q · filed 2024-05-10
$46.47M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$11.18M
10-Q · filed 2024-02-12
$22.51M
10-Q · filed 2024-02-12
$34.38M
derived: sum of 3 quarters · filed 2024-02-12
$48.04M
derived: sum of 4 quarters · filed 2024-02-12
2022-09-30$11.33M
10-Q · filed 2023-11-09
$23.20M
derived: sum of 2 quarters · filed 2023-11-09
$36.85M
derived: sum of 3 quarters · filed 2023-11-09
$49.70M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$11.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-15
$25.52M
derived: sum of 2 quarters · filed 2023-09-15
$38.37M
derived: sum of 3 quarters · filed 2023-09-15
$49.69M
10-K · filed 2023-09-15
2022-03-31$13.65M
10-Q · filed 2023-05-11
$26.50M
derived: sum of 2 quarters · filed 2023-05-11
$37.82M
10-Q · filed 2023-05-11
$52.61M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$12.84M
10-Q · filed 2023-02-10
$24.17M
10-Q · filed 2023-02-10
$38.96M
derived: sum of 3 quarters · filed 2023-02-10
$53.37M
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30$11.33M
10-Q · filed 2022-11-10
$26.11M
derived: sum of 2 quarters · filed 2022-11-10
$40.52M
derived: sum of 3 quarters · filed 2022-11-10
$52.61M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$14.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13
$29.20M
derived: sum of 2 quarters · filed 2022-09-13
$41.28M
derived: sum of 3 quarters · filed 2022-09-13
$54.08M
10-K · filed 2022-09-13
2021-03-31$14.41M
10-Q · filed 2022-05-12
$26.49M
derived: sum of 2 quarters · filed 2022-05-12
$39.29M
10-Q · filed 2022-05-12
$51.38M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$12.08M
10-Q · filed 2022-02-10
$24.88M
10-Q · filed 2022-02-10
$36.97M
derived: sum of 3 quarters · filed 2022-02-10
$48.75M
derived: sum of 4 quarters · filed 2022-02-10
2020-09-30$12.80M
10-Q · filed 2021-11-10
$24.88M
derived: sum of 2 quarters · filed 2021-11-10
$36.66M
derived: sum of 3 quarters · filed 2021-11-10
$48.83M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$12.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-02
$23.86M
derived: sum of 2 quarters · filed 2021-09-02
$36.03M
derived: sum of 3 quarters · filed 2021-09-02
$46.04M
10-K · filed 2021-09-02
2020-03-31$11.78M
10-Q · filed 2021-05-13
$23.95M
derived: sum of 2 quarters · filed 2021-05-13
$33.96M
10-Q · filed 2021-05-13
$45.96M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$12.17M
10-Q · filed 2021-02-12
$22.18M
10-Q · filed 2021-02-12
$34.18M
derived: sum of 3 quarters · filed 2021-02-12
$46.18M
derived: sum of 4 quarters · filed 2021-02-12
2019-09-30$10.01M
10-Q · filed 2020-11-12
$22.01M
derived: sum of 2 quarters · filed 2020-11-12
$34.01M
derived: sum of 3 quarters · filed 2020-11-12
$44.68M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30$12.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23
$24.00M
derived: sum of 2 quarters · filed 2020-09-23
$34.67M
derived: sum of 3 quarters · filed 2020-09-23
$43.76M
10-K · filed 2020-09-23
2019-03-31$11.99M
10-Q · filed 2020-05-13
$22.67M
derived: sum of 2 quarters · filed 2020-05-13
$31.75M
10-Q · filed 2020-05-13
$42.85M
derived: sum of 4 quarters · filed 2020-05-13
2018-12-31$10.67M
10-Q · filed 2020-02-12
$19.76M
10-Q · filed 2020-02-12
$30.86M
derived: sum of 3 quarters · filed 2020-02-12
$39.96M
derived: sum of 4 quarters · filed 2020-02-12
2018-09-30$9.09M
10-Q · filed 2019-11-13
$20.18M
derived: sum of 2 quarters · filed 2019-11-13
$29.29M
derived: sum of 3 quarters · filed 2019-11-13
$39.04M
derived: sum of 4 quarters · filed 2019-11-13
2018-06-30$11.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29
$20.20M
derived: sum of 2 quarters · filed 2019-08-29
$29.96M
derived: sum of 3 quarters · filed 2019-08-29
$38.72M
10-K · filed 2019-08-29
2018-03-31$9.11M
10-Q · filed 2019-05-15
$18.86M
derived: sum of 2 quarters · filed 2019-05-15
$27.62M
10-Q · filed 2019-05-15
$27.62M
10-Q · filed 2018-05-09
2017-12-31$9.75M
10-Q · filed 2019-02-13
$18.52M
10-Q · filed 2019-02-13
2017-09-30$8.77M
10-Q · filed 2018-11-09
2017-06-30$40.29M
10-K · filed 2018-09-12
2017-03-31$9.31M
10-Q · filed 2018-05-09
$30.75M
10-Q · filed 2018-05-09